The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
It was reported that a patient with a 32mm 4450m annuloplasty ring, implanted in the mitral position, underwent a valve-in-ring procedure after an implant duration of six (6) years, six (6) months due to mitral regurgitation.The root cause of this identified to be distortion of the annuloplasty ring.The procedure was performed with a 29mm 9600tfx transcatheter valve.The patient expired due to pulmonary issues.
|
The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.Although the product was not returned and there is an allegation, regurgitation after an implant duration of 6 years is most commonly related to patient factors, and is not a result of a manufacturing non-conformance.Additionally, there is no evidence of product failure with regard to design, reliability, or use error.Thus, an engineering evaluation will not be performed.The causes of surgical or percutaneous intervention for failed annuloplasty repairs are well documented in the literature.This is primarily due to progression of native valvular disease or technical failures and is not related to device malfunction.This may present as recurrent regurgitation and/or stenosis.Unlike prosthetic heart valves, annuloplasty rings are an adjunct to the valve repair.Re-operations are primarily the result of a progression of disease, the patient's baseline hemodynamics, or technical failures and are not evidence of product malfunctions.The most likely cause is patient factors, including progression of patient's disease.
|